AED.BR
Company Description
Aedifica is a Belgian listed company that offers sustainable real estate solutions to professional operators that provide care to people with care needs throughout Europe. To realise that mission, Aedifica has specialised in investments in quality European healthcare real estate, with a particular focus on the care needs of the elderly. Aedifica has established itself in recent years as a leader in the European listed real estate sector and has the ambition to further expand this position in the coming years. By investing in quality buildings that generate recurring and indexed rental income and offer potential for capital gains, Aedifica aims to offer its shareholders a reliable and sustainable real estate investment with an attractive yield. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019). Since March 2020, Aedifica is part of the BEL 20, the leading share index of Euronext Brussels.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 370.19M | 347.73M | 321.37M | 277.07M | 242.73M | 191.03M | 121.22M | 94.23M | 81.61M | 61.91M | 51.75M | 41.81M |
| Net Income | 244.43M | 204.83M | 24.54M | 331.78M | 281.82M | 103.89M | 103.89M | 71.86M | 63.36M | 40.27M | 45.16M | 21.39M |
| EPS | 5.14 | 4.31 | 0.56 | 8.71 | 7.91 | 3.69 | 5.14 | 3.99 | 3.80 | 2.60 | 3.77 | 1.92 |
| Free Cash Flow | 262.19M | 247.89M | 228.54M | 217.73M | 194.01M | (23.24M) | 88.70M | 83.20M | 68.39M | 49.58M | N/A | N/A |
| FCF / Share | 5.51 | 5.21 | 5.23 | 5.58 | 5.45 | -0.83 | 4.39 | 4.62 | 4.10 | 3.21 | N/A | N/A |
| Operating CF | 262.53M | 248.50M | 229.53M | 218.60M | 198.27M | 141.32M | 88.76M | 84.99M | 69.15M | 50.09M | N/A | N/A |
| Total Assets | 6.48B | 6.46B | 6.18B | 6.09B | 5.16B | 4.07B | 2.39B | 1.77B | 1.57B | 1.17B | N/A | N/A |
| Total Debt | 2.49B | 2.59B | 2.36B | 2.53B | 2.14B | 1.72B | 856.51M | 739.76M | 613.96M | 478.75M | N/A | N/A |
| Cash & Equiv | 21.95M | 18.45M | 18.25M | 13.89M | 15.34M | 23.55M | 15.40M | 10.59M | 8.13M | 4.95M | N/A | N/A |
| Book Value | 3.66B | 3.64B | 3.58B | 3.28B | 2.78B | 2.17B | 1.43B | 941.65M | 888.04M | 620.75M | N/A | N/A |
| Return on Equity | 0.07 | 0.06 | 0.01 | 0.10 | 0.10 | 0.05 | 0.07 | 0.08 | 0.07 | 0.06 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 118.00M | 90.28M | 94.00M | 90.08M | 95.83M | 88.48M | 88.73M | 86.25M | 84.06M | 81.61M | 81.16M | 79.82M |
| Net Income | 432.33M | 50.32M | 80.98M | 50.34M | 62.80M | 33.83M | 28.84M | 66.52M | 75.64M | (65.01M) | 32.76M | 40.65M |
| EPS | 7.68 | 1.06 | 1.70 | 1.06 | 1.32 | 0.71 | 0.61 | 1.40 | 1.59 | -1.37 | 0.69 | 1.02 |
| Free Cash Flow | N/A | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FCF / Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating CF | N/A | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 13.02B | 6.48B | 6.43B | 6.44B | 6.40B | 6.46B | 6.41B | 6.37B | 6.28B | 6.18B | 6.24B | 6.15B |
| Total Debt | 4.89B | 2.49B | 2.50B | 2.58B | 2.40B | 2.59B | 2.50B | 2.51B | 2.32B | 2.36B | 2.28B | 2.60B |
| Cash & Equiv | 45.00M | 21.95M | 20.50M | 61.76M | 51.88M | 18.45M | 15.58M | 21.59M | 16.61M | 18.25M | 17.63M | 14.47M |
| Book Value | 6.66B | 3.66B | 3.61B | 3.55B | 3.70B | 3.64B | 3.61B | 3.56B | 3.66B | 3.58B | 3.64B | 3.24B |
| Return on Equity | 0.06 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | -0.02 | 0.01 | 0.01 |